Eckert & Ziegler Strahlen- und Medizintechnik AG

M&A Activity • Mar 4, 2004

News Details

Corporate | 4 March 2004 10:24

Eckert & Ziegler Acquires a Majority Stake in Sales Subsidiary

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Berlin, March 4, 2004. Eckert & Ziegler AG (ISIN DE 0005659700), has increased its 25% stake in its sales subsidiary, Isotope Products Europe Blaseg GmbH, Waldburg (IPE), and acquired a majority holding in the Baden-Württemberg-based company. IPE sells nuclear-medical products and products based on isotope technology that are used for imaging processes in diagnosis as well as in specialized metrological applications in industry. Eckert & Ziegler plans to expand IPE into an enlarged sales and marketing organization for nuclear-medical products and products based on isotope technology. The Executive Board For further questions please contact: Eckert & Ziegler AG Karolin Riehle Investor Relations Robert-Rössle-Str. 10 13125 Berlin, Germany Phone: +49 (0) 30 / 94 10 84-138 http://www.ezag.de end of message, (c)DGAP 04.03.2004 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 041024 Mär 04